As of 2025-07-13, the Intrinsic Value of Innovation Pharmaceuticals Inc (IPIX) is -0.19 USD. This IPIX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Innovation Pharmaceuticals Inc is -64,941.26%.
Based on its market price of 0.00 USD and our intrinsic valuation, Innovation Pharmaceuticals Inc (IPIX) is overvalued by 64,941.26%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.19 - -0.19 | -0.19 | -64,941.26% |
| P/E | (0.00) - (0.25) | (0.01) | -2066.4% |
| DDM - Stable | (0.03) - (0.06) | (0.04) | -14731.3% |
| DDM - Multi | (0.02) - (0.04) | (0.02) | -8109.5% |
| Market Cap (mil) | 0.05 |
| Beta | -4.75 |
| Outstanding shares (mil) | 177.65 |
| Enterprise Value (mil) | -0.12 |
| Market risk premium | 4.60% |
| Cost of Equity | 35.15% |
| Cost of Debt | 5.00% |
| WACC | 5.99% |